|
gptkbp:instance_of
|
gptkb:medical_devices
|
|
gptkbp:acquisition
|
gptkb:Biosense_Webster
gptkb:Celo_Nova_Biosciences
gptkb:Guidant_Corporation
|
|
gptkbp:awards
|
gptkb:Fortune_500
Best Places to Work
Top 100 Global Innovators
|
|
gptkbp:ceo
|
gptkb:Michael_Mahoney
|
|
gptkbp:employees
|
approximately 38,000
|
|
gptkbp:focus_area
|
endoscopy
neuromodulation
urology
interventional radiology
cardiovascular
|
|
gptkbp:founded
|
gptkb:1979
|
|
gptkbp:founder
|
gptkb:John_Abele
|
|
gptkbp:global_presence
|
over 100 countries
|
|
gptkbp:headcount
|
38,000
|
|
gptkbp:headquarters
|
gptkb:Marlborough,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Boston Scientific
|
|
gptkbp:industry
|
gptkb:medical_devices
|
|
gptkbp:invention
|
over 10,000
|
|
gptkbp:market_cap
|
$50 billion (2023)
|
|
gptkbp:partnership
|
gptkb:Boston_University
gptkb:Abbott_Laboratories
gptkb:Harvard_Medical_School
gptkb:Siemens_Healthineers
gptkb:Medtronic
|
|
gptkbp:products
|
stents
catheters
pacemakers
|
|
gptkbp:research_and_development
|
$1.5 billion annually
|
|
gptkbp:revenue
|
$11.9 billion (2022)
|
|
gptkbp:stock_symbol
|
BSX
|
|
gptkbp:subsidiary
|
gptkb:Biosense_Webster
gptkb:Aptus_Endosystems
gptkb:Celo_Nova_Biosciences
gptkb:Endo_Choice
gptkb:Guidant_Corporation
|
|
gptkbp:sustainability_initiatives
|
community engagement
diversity and inclusion
environmental responsibility
|
|
gptkbp:traded_on
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:trademark
|
gptkb:Eluvia_Drug-Eluting_Stent
gptkb:Lotus_Valve_System
gptkb:Spy_Glass_System
gptkb:Watchman_Device
Resonant Catheter
|
|
gptkbp:website
|
www.bostonscientific.com
|
|
gptkbp:bfsParent
|
gptkb:W3_C
|
|
gptkbp:bfsLayer
|
3
|